Examination Report |
1 | Additional Representation Sheet | 25 Mar 2010 |
10 | TM-M(REQUEST SUBMITTING AUTHORISATION OF AGENT) | 22 Sep 2022 |
11 | TM-M(CORRECTION OF CLERICAL ERROR OR FOR AMENDMENT U/R 37) | 22 Sep 2022 |
2 | TM-1 | 25 Mar 2010 |
3 | Reply to Exam Report (MIS-R) | 04 May 2013 |
4 | TM-16 | 07 Jan 2015 |
5 | Authorization Document (POA) | 07 Jan 2015 |
6 | Hearing Notice | 27 Apr 2015 |
7 | TM-16 | 21 May 2015 |
8 | TM-5 | 03 Sep 2015 |
9 | Applicant's affidavit Rule | 10 Jan 2018 |
1 | Opposition Notice | 4051986 | 01 Oct 2016 | |
2 | Opposition Counter Statement | 5094318 | 2183980 | 07 Sep 2017 |
3 | Hearing Notice | 13786996 | 5660720 | 14 Jul 2022 |
The application for Acelast was made on 25 March 2010.
The trademark applicant for Acelast is SUN PHARMACEUTICAL INDUSTRIES.
Acelast is applied in class(es) 5.
Application for Acelast is on Opposed stage.
Application Id allotted to Acelast is 1941058.
Acelast filed with the Intellectual property office as a WORD.